<?xml version="1.0" encoding="UTF-8"?>
<p>A novel antipsychotic agent with a mechanism of action different from all currently marketed typical and atypical antipsychotics is aripiprazole. This quinoline derivative exerts potent partial agonistic action on D
 <sub>2 </sub>and 5-HT
 <sub>1A </sub>receptors and antagonistic properties at 5-HT
 <sub>2A </sub>receptors. Aripiprazole claims to be the first agent of a third generation of antipsychotics, the so-called "dopamine-serotonin stabilizers"[
 <xref ref-type="bibr" rid="B14">14</xref>].
</p>
